What Massmedica does

Massmedica S.A. is a Warsaw-headquartered Polish distributor of medical aesthetic, regenerative medicine, orthopedic, and sports medicine products, operating as a public limited company listed on the Warsaw Stock Exchange NewConnect market under ticker MSM. The company sources products from a portfolio of international manufacturers — including MediXa (Italy) for the Ejal and Hyamino lines, GCS Co., Ltd. (Korea) for the INOBELLE hybrid HA fillers, JMC Co., Ltd. (Korea) for the VeAge PLLA biostimulator, Yasha Medical for the ZQ-II MAP and PLLA-mPEG regenerative preparations, and Albomed GmbH for the KD Intra-Articular Gel orthopedic injection — and distributes them in Poland under exclusive or core partnership agreements. The portfolio spans Class III injectable medical devices, chemical peels, carboxytherapy gels, nutritional supplements (Pro-Collagenium, ProLon 5-day and ReSet), and consumer skincare, with several CE-marked and ISO 13485-governed product lines.

The business runs two parallel go-to-market motions: a credential-verified professional e-commerce shop selling Class III devices and aesthetic medicine consumables to doctors, dermatologists, orthopedists and sports medicine specialists (with individual offer requests and personalized pricing handled by sales representatives), and a direct-to-consumer e-commerce storefront for over-the-counter skincare, supplements and wellness kits. Distribution is exclusively domestic, with physical pickup at the Warsaw headquarters via an InPost/DHL partnership. Revenue mechanics are predominantly one-time unit purchases at prices ranging from roughly 139 PLN for entry consumer SKUs to over 1,850 PLN per multi-treatment pack, supplemented by a minor recurring newsletter content subscription at 39 PLN gross. The company also distributes Corin Limited's OMNIBotics robotic arthroplasty system under an exclusive arrangement and has supplied Chunli-manufactured knee endoprosthesis sets via public tenders.

Corporate structure includes a wholly-owned subsidiary established in December 2019, and the company maintains an active investor relations function with ESPI/EBI filings, quarterly and annual reporting, and regular general meetings. Strategic activity has emphasized supply-side portfolio breadth through new manufacturer agreements and product-line additions, with operational scale (51-100 employees) and registered share capital (241,489.90 PLN) reflecting a small-cap, single-country distribution profile.

Name

Massmedica

Legal name

Massmedica S.A.

Website

https://massmedica.com

Company type

Public

Operating status

Operating

Headcount range

51–100 employees

Short description

Massmedica S.A. is a Warsaw-based Polish distributor of medical aesthetic, regenerative, and orthopedic products, serving both credentialed healthcare professionals and individual consumers via separate domestic e-commerce channels.

Ownership category

akta.pro rank

Product category

Medical Aesthetic & Regenerative Medicine Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Health and Personal Care Retailers (4561)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industry

Mass Beauty & Drugstore Beauty Distribution (CRAOAEAA)

Keywords

• Aesthetic medicine distribution
• Medical device wholesale
• Dermal filler products
• Orthopedic injections supply
• Regenerative medicine products

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. E-commerce Retail Sales: Direct product sales through Massmedica's e-commerce platforms for both professional and consumer segments. Products include dermal fillers, skin boosters, orthopedic products, supplements, and fasting mimicking diet programs sold at various price points from approximately 150 PLN to over 2,000 PLN per unit.
2. Newsletter Content Subscriptions: Newsletter service with optional paid access to digital content for 39 PLN gross. Free newsletter provides marketing communications about promotions and new products.
3. Professional B2B Sales: B2B sales to medical professionals including individual offer requests where company representatives present personalized pricing. Professional-only product access requiring medical credential verification.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Massmedica S.A. is a Polish wholesale distributor that supplies and sells medical aesthetic, regenerative medicine, orthopedic, and sports medicine products. Its portfolio spans hyaluronic acid dermal fillers, PLLA biostimulators, mesotherapy injectables, carboxytherapy gels, chemical peels, dietary supplements, fasting-mimicking diet programs, and intra-articular joint injections. The company runs two parallel storefronts: a professional-only shop (credential-verified, for clinicians and medical practitioners) and a consumer e-commerce shop, distributing exclusive international brands in the Polish market.

Product overview

Massmedica S.A. jest hurtownią specjalizującą się w medycynie estetycznej i regeneracyjnej oraz ortopedii i medycynie sportowej. Firma prowadzi oddzielne sklepy dla konsumentów (produkty bez recepty: suplementy, kosmetyki, narzędzia do zabiegów domowych) i profesjonalistów (wyroby medyczne klasy III, stymulatory tkankowe, wypełniacze HA, produkty ortopedyczne). Portfolio obejmuje: wypełniacze kwasu hialuronowego (INOBELLE F/D/S, BioHyalux, FILL-me), stymulatory tkankowe (Ejal40, VeAge PLLA, ZQ-II PLLA), preparaty do mezoterapii (Hyamino Care, Hyamino Hair, Hyamino Firm), produkty ortopedyczne (KD Intra-Articular Gel), karboksyterapię (CO2Lift V, CO2Lift PRO), ochronę przeciwsłoneczną (Ejal Sun Block SPF50+, Ejal Sun Protection), suplementy diety (Pro-Collagenium, ProLon 5-day, ProLon ReSet), peelingi chemiczne (JPX3), regenerację skóry głowy (ZQ-II MAP) oraz hialuronidazę.

Differentiator

Problem solved

Functional benefit

Products and services

• INOBELLE F/D/S and INOBELLE F+/D+/S+ Hybrid HA Fillers Hybrid hyaluronic acid dermal fillers combining chemical and physical cross-linking for high elasticity, durability, and 6–12 month lasting effect. Manufactured by GCS Co., Ltd. (Korea), variants available with lidocaine. Targeted at medical professionals performing facial soft tissue correction.
• BioHyalux HA Fillers (Basic, Deep Dermis, Fine Lines, Lips) Hyaluronic acid filler line offering variants for different facial tissue planes and indications (basic volume, deep dermis, fine lines, lips) for medical professionals.
• FILL-me (1, 2, 3) HA Fillers with Amino Acids Italian injectable soft tissue correction products combining cross-linked hyaluronic acid with amino acids (glycine and proline) to deliver simultaneous filling and tissue stimulation. Targeted at medical professionals.
• Ejal40 (1x2ml) Tissue Stimulator Class III certified medical device — sterile hyaluronic acid gel (20 mg/ml) for deep skin biorestructuring. Targeted at medical professionals.
• VeAge PLLA Collagen Biostimulator CE 1434 certified poly-L-lactic acid (PLLA) biostimulator for deep skin regeneration, volume restoration, and wrinkle reduction via fibroblast stimulation and neocollagenesis, with effects lasting up to 24 months. Targeted at medical professionals in aesthetic medicine.
• ZQ-II PLLA Nutrients Fills (mPEG technology) Innovative mesotherapy preparation combining poly-lactic acid (PLLA) with mPEG technology for skin regeneration, improved firmness, and uneven skin tone correction. Targeted at medical professionals.
• ZQ-II MAP (Mussel Adhesive Protein Hair & Scalp Preparation) Scalp and hair regeneration preparation using mussel adhesive protein (MAP) to create nanoscale biological scaffolding in the skin, binding with collagen and ECM elements to stabilize the hair growth environment. Targeted at medical professionals.
• Hyamino Care Mesotherapy (50, 75, 125) Injectable biorevitalization products with non-crosslinked hyaluronic acid and a complex of collagen-precursor amino acids. Targeted at medical professionals performing mesotherapy.
• Hyamino Hair Biostimulating Cocktail Professional biostimulating mesotherapy cocktail with hyaluronic acid, amino acids, and trace elements for scalp biostimulation. Targeted at medical professionals.
• Hyamino Firm Biorevitalization Preparation Biorevitalization preparation combining hyaluronic acid, amino acids, and biomimetic peptide Acetyl Hexapeptide-3 for skin firmness. Targeted at medical professionals.
• HyaluronDase 1500 UI Enzyme Powdered hyaluronidase enzyme (1500 IU) for reconstitution, intended for diffusion of active ingredients and potential correction of HA filler procedures. Targeted at medical professionals.
• JPX3 Pre Peeling / JPX3 Bio Chemical Peel Range Professional chemical peeling line: JPX3 Pre Peeling prepares the skin prior to peeling, and JPX3 Bio is the main peeling agent. Targeted at medical professionals.
• CO2Lift V Carboxy-Gel (Intimate Area) Carboxy-gel designed for intimate-area carboxytherapy treatments in aesthetic medicine, delivering carbon dioxide transdermally. Packaged in multi-treatment packs. Targeted at medical professionals.
• CO2Lift PRO Carboxy-Gel (Professional) Professional-grade carboxy-gel for in-clinic aesthetic carboxytherapy treatments, delivering carbon dioxide transdermally. Targeted at medical professionals.
• KD Intra-Articular Gel 2.5% (Solo 120) Intra-articular injection with the highest hyaluronic acid concentration (2.5%) available on the Polish market, for the treatment of knee joint osteoarthritis. Targeted at orthopedic and sports medicine professionals.
• ProLon 5-Day Fasting Mimicking Diet Program Scientifically developed 5-day nutritional program based on patented FMD technology that allows cells to enter a fasting state while still consuming food, triggering autophagy and cellular regeneration. Sold to consumers and professionals in Poland.
• ProLon ReSet 1-Day Fasting Mimicking Kit 1-day nutritional kit that transitions the body into a fasting state using ProLon FMD technology. Available in single units and 2/3/4-pack bundles. Sold primarily to consumers with multi-pack discounts.
• Pro-Collagenium Marine Collagen with Vitamin C Supplement Highly concentrated (10,000 mg) liquid marine collagen dietary supplement with vitamin C, intended for regeneration of skin structure from within. Sold directly to consumers; publicly priced at 309 PLN.
• Ejal Sun Block SPF50+ Body Sunscreen Italian (Medixa) brand SPF50+ body sunscreen providing UVA/UVB protection, formulated with hyaluronic acid and sweet almond oil. Consumer skincare product distributed by Massmedica in Poland.
• Ejal Sun Protection Face SPF30 Cream Italian (Medixa) brand SPF30 face sunscreen cream with moisturizing and skin-regenerating properties. Consumer skincare product distributed by Massmedica in Poland.
• Massmedica Newsletter Premium Digital Content Subscription Optional paid newsletter premium digital content subscription (39 PLN gross) providing access to premium marketing/editorial materials; free newsletter version delivers promotional and new-product communications. Targeted at retail consumers and professionals.

Quantifiable outcome

• Pro-Collagenium reduces deep wrinkles by 30% after 12 weeks
• +4 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Yasha Medical Instrument Co., LtdcoreTechnology or IntegrationManufacturer of ZQ-II MAP products including PLLA preparations for skin regeneration and hair follicle treatment. Massmedica distributes these products in Poland.
• GCS Co., Ltd. (Korea)coreTechnology or IntegrationKorean manufacturer of INOBELLE hybrid hyaluronic acid fillers. INOBELLE F/D/S variants with lidocaine options are distributed by Massmedica.
• MediXa Srl (Włochy/Italy)coreTechnology or IntegrationItalian manufacturer of Ejal brand products including Ejal40 skin booster, Ejal Sun Protection SPF products, Hyamino line, and HyaluronDase. Major product line for Massmedica.
• Albomed GmbHcoreTechnology or IntegrationManufacturer of KD Intra-Articular Gel 2.5% (Solo 120) orthopedic joint injection product with highest HA concentration available on Polish market.
• JMC Co., Ltd.coreTechnology or IntegrationManufacturer of VeAge PLLA biostimulator product certified CE 1434, distributed by Massmedica for aesthetic medicine applications.
• Corin LimitedcoreChannel Partner/ Reseller/ DistributorExclusive distribution agreement for OMNIBotics surgical robot for knee arthroplasty. First operation in Europe using Fine Osteonomy system performed with Massmedica.
• ChunliminorChannel Partner/ Reseller/ DistributorChinese manufacturer of knee endoprostheses. Massmedica won tender for delivery of 200 knee endoprosthesis sets.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Teoxane Laboratories: Swiss developer and distributor of HA dermal fillers (TEOSYAL range) and skin boosters, with established European aesthetic distribution networks. Comparable as a premium HA filler and biostimulator specialist.
• Sinclair Pharma: Specialty aesthetics company distributing HA fillers, biostimulators (e.g., Ellansé), and complementary products to clinicians across Europe. Directly comparable to Massmedica's professional aesthetic distribution model.
• Vivacy Laboratories: French manufacturer of STYLAGE HA fillers and mesotherapy products distributed via professional aesthetic channels across Europe. Comparable product overlap (HA fillers, mesotherapy) and distribution model.
• Croma-Pharma: Austrian manufacturer and distributor of HA-based aesthetic products (Princess fillers) sold through professional channels across Europe. Closely comparable business model combining proprietary manufacturing with multi-country aesthetic distribution.
• Professional Dietetics (L-Nutra): US/Italian developer of the ProLon Fasting Mimicking Diet program — Massmedica is a ProLon distributor. Comparable as a partner-principal relationship relevant to Massmedica's longevity/wellness line.

Broad incumbents

• AbbVie (Allergan Aesthetics): Owns Allergan Aesthetics (Juvéderm, CoolSculpting, Botox) and operates direct European sales. Broad incumbent and largest competitor in the HA filler category that Massmedica distributes.
• Galderma: Global specialty dermatology and aesthetics leader (Restylane, Sculptra, Dysport). Comparable broader incumbent competing against Massmedica's distributed brands for the same Polish clinician customers.
• Merz Aesthetics: Major aesthetics incumbent (Belotero, Radiesse, Xeomin) with direct European sales infrastructure. Broad incumbent overlapping with Massmedica's professional aesthetic catalog in Poland.

Regional players

• Hugel Inc. Korean aesthetics company (botulinum toxin, HA fillers, PDO threads) exporting through European distributors. Relevant because Massmedica distributes other Korean manufacturers (GCS, JMC) and faces competitive overlap with Hugel in the European channel.
• Pelion Healthcare Group: Large Polish/Central European pharmaceutical wholesale and distribution group. Comparable as a regional incumbent against which Massmedica competes for both supplier relationships and pharmacy/clinic customers in Poland.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/massmedicapro
• LinkedInlinkedin.com/company/massmedica
• Instagraminstagram.com/massmedica

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Massmedica